-

6th Perinatal Stem Cell Society Congress (Salt Lake City, United States - March 4-6, 2020) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "6th Perinatal Stem Cell Society Congress" conference has been added to ResearchAndMarkets.com's offering.

The International Perinatal Stem Cell Society, Inc. is a non-profit organization founded on the basic principle that stem cells from perinatal tissues contain enormous, untapped life potential to treat many diseases and disorders.

Benefits of Registration:

  • Access to leading-edge research from pioneers across the field.
  • Networking opportunities to cultivate relationships with relevant and engaged colleagues and organizations.
  • A unique opportunity to learn from the leading clinicians utilizing cellular therapies in their practices.

Agenda:

Thursday, March 5, 2020

7:00 - 8:25 Breakfast in Exhibit Hall

8:25 - 8:30

Kyle Cetrulo

Welcome

8:30 - 9:00

Renee Nordland

How Cord Tissue Changed My Son's Life

9:00 - 9:30

Frances Verter, PhD

Clinical Trials with Perinatal Tissues and Cells

9:30 - 10:00

Tomasz Baran MD, MBA

FamiCord's Clinical Experience with WJ Derived Products in Multiple Clinical Applications

10:00 - 10:30 Exhibit Hall Break

10:30 - 11:00

Neil Riordan, PA, PhD

Results From Panama Clinical Trials Using Umbilical Cord MSCs: MultioleSclerosis and Autism

11:00 - 12:00

Joanne Kurtzberg, MD

Extending Perinatal Therapies for the Brain

12:00 - 1:00 Lunch

1:00 - 1:30

Rouzbeh R. Taghizadeh, PhD

Umbilical Cord Tissue Processing Technologies for Perinatal MSC Banking

1:30 - 2:00

Serhiy Forostyak, MD

Perinatal Tissue Derivatives in Tissue Regeneration: From Research to Clinical Applications

2:00 - 2:30

Joshua Hare, MD

Comparison of Umbilical Cord Tissue MSCs and Bone Marrow MSCs

2:30 - 3:00

Rebeca Lim, PhD

Exosome Therapy for Bronchopulmonary Dysplasia - Are We Ready for Cell-free Regenerative Medicine?

3:00 - 3:30 Exhibit Hall Break

3:30 - 4:00

Timothy Ganey, PhD

Quantification of Exosome Product

4:00 - 4:30

Ben Noren

Cell Microencapsulation for Enhanced Regeneration of Tissues

4:30 - 5:00

John Wetherell, PhD

Understand How IP Drives Your Company Decision Making Process

Networking Cocktail Reception & Dinner

Friday, March 6, 2020

7:00 - 8:30 Breakfast in Exhibit Hall

8:30 - 9:00

Dennis Lox, MD

Why A Successful Sports & Regenerative Medicine Specialist Doesn't Use Perinatal Products

9:00 - 9:30

Duncan Ross, PhD

Exosome Characterization and Visualization

9:30 - 10:00

Saadiq F. El-Amin III, MD, PhD

Regenerative Medicine in Elite and Professional Athletes

10:00 - 10:30 Exhibit Hall Break

10:30 - 11:00

Regan Archibald, LAc, FMP, CSSAc

Ending the Pain Crisis with TCM, Peptides and Perinatal Allographs

11:00 - 11:30

Ian White, PhD

Regeneration 101: Amniosomes in Regenerative Medicine

11:30 - 1:00 Lunch

1:00 - 1:30

FDA Representative

An Update on the FDA's Stance on Perinatal Products and the 361 Industry

1:30 - 2:00

Mike Druckman

Regulatory Questions All 361 Companies Should Understand

2:00 - 2:30

Barbara Krutchkoff, PhD FAARM

A Road Map to Compliance

2:30 - 3:00 Panel

FDA Representative

Mike Druckman

Barbara Krutchkoff, PhD

Timothy Ganey, PhD

3:00 - 3:30 Exhibit Hall Break

3:30 - 4:00

Jeremy J. Lim, PhD

Biological Properties of Dehydrated Human Amnion/Chorion Membrane and Umbilical Cord Allografts for Soft Tissue Healing

4:00 - 4:30

Sean Murphy, PhD

Amnion Membrane-Derived Cells and Materials for Skin Wound Treatment

4:30 - 5:00

Ramon Coronado, MSc, PhD

Exosomes to Treat Cancer

Speakers

  • Kyle Cetrulo, President and Founder, Perinatal Stem Cell Society, Co-Founder and CEO, Auxocell Laboratories, Inc
  • Renee Nordland, Parent Advocate and the Founder of the Cord Tissue for Autism FaceBook Group
  • Frances Verter, PhD, Founder and Director of the Parent's Guide to Cord Blood Foundation, Frances Verter holds a PhD in astrophysics and worked at NASA Goddard for decades
  • Tomasz Baran MD, MBA, Tomasz Baran is Board Member of PBKM (Polish Stem Cell Bank) operating in multiple European countries as FamiCord Group
  • Neil Riordan, PA, PhD, Founder and chief scientist at the Stem Cell Institute in Panama City, Panama, and co-founder of the Riordan-McKenna Institute in Southlake, Texas
  • Joanne Kurtzberg, MD, Director, Marcus Center for Cellular Cures (MC3) , Director, Pediatric Blood and Marrow Transplant Program, Director, Carolinas Cord Blood Bank, Co-Director, Stem Cell Laboratory
  • Rouzbeh R. Taghizadeh, PhD, Director, Secretary, and Founder of the Perinatal Stem Cell Society, Chief Scientific Officer, Auxocell Laboratories, Inc
  • Dr. Serhiy Forostyak, Chief Scientific Officer (CSO) in the leading Czech Biotechnological company PrimeCell
  • Joshua Hare, MD, Chief Sciences Officer, Senior Associate Dean for Experimental and Cellular Therapeutics, Director of the Interdisciplinary Stem Cell Institute (ISCI), and Louis Lemberg Professor of Medicine at the University of Miami Miller School of Medicine
  • Dr Rebecca Lim, PhD, Department of Obstetrics and Gynaecology, Monash University and The Ritchie Centre, Hudson Institute of Medical Research. Dr Lim holds adjunct appointments at the Australian Regenerative Medicine Institute and Chinese University Hong Kong. She serves on the scientific advisory board of the Centre for Commercialisation of Regenerative Medicine - Australia, and is a director of Meluha Capital, a Malaysian-owned biotech company
  • Timothy Ganey, PhD, Tim Ganey is Chief Scientific Officer for Vivex Biomedical, Marietta, GA; Director of the Atlanta Learning Center, and Director of Orthopedic Research at the Atlanta Medical Center; Chief Technical Officer, Spinplant GmbH, Leipzig, Germany; a Faculty Member of the TRM Facility in Leipzig Germany, and a faculty member at Nova Southeastern, Ft. Lauderdale, FL
  • Ben Noren, Founder of VisibleFlow, Principal Investigator at CellDrop
  • John Wetherell, PhD , Pillsbury's San Diego Intellectual Property Leader, Board of Directors of the Cystic Fibrosis Foundation
  • Kyle Cetrulo, Dennis Lox, MD, Clinical practice in Beverly Hills, California and the Tampa Bay, Florida area. Author and Speaker
  • Duncan Ross, Ph.D., Founder of Kimera Labs, Inc
  • Saadiq F. El-Amin III, MD, PhD, Chief Science Officer for BioIntegrate, Medical Expert on Fox 5 Atlanta Play to Win TV show, Owner of the El-Amin Orthopaedics & Sports Medicine Institute in Atlanta
  • Regan Archibald, LAc, FMP, CSSAc, Create the award-winning clinic, East West Health, which is one of the few clinics in the nation to successfully integrate traditional eastern medicine, stem cell therapy, peptides and functional medicine
  • Ian White, Ph.D., Founder of Self Care Regeneration, LLC, Chief Science Officer at REGENiSELF, LLC and lead Scientific Advisor for IMAC Regeneration Centers
  • Mike Druckman, Chairs the Hogan Lovell's Cell, Tissue, and Gene Therapies Working Group
  • Barbara Krutchkoff, PhD FAARM, Executive Director, Institute of Regenerative and Cellular Medicine, CEO of A3Cell/Consultancy, Visiting Lecturer, Universite Paris Descartes, Director of Cell and Gene Applications USAuthentic Trading
  • Jeremy J. Lim, PhD, Senior Biomedical Engineer at MiMedx Group, Inc
  • Sean Murphy, PhD, Assistant Professor, Wake Forest Institute for Regenerative Medicine, Director/Secretary and Co-founder of the Perinatal Stem Cell Society
  • Ramon Coronado, MSc, PhD, Executive Director Lester Smith Medical Research Institute

For more information about this conference visit https://www.researchandmarkets.com/r/5wz444

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Poland Investment Funds and Asset Management Market Report 2026, Profiles of TFI, Pekao, Santander, PKO, Allianz, Goldman Sachs - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investment Funds and Asset Management Market in Poland, 2024-2026" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive overview of the investment funds and asset management sector in Poland. Analysis covers the main pillars of the market, including: mutual funds, insurance, and pension assets. The report also mid-term forecast of key volumes for the period 2025-2027. The data has been presented in a form of horizontal pr...

Europe Data Center Colocation Market Outlook & Forecast Report 2025-2030 Featuring Major Players - Digital Realty, Equinix, NTT DATA, Global Switch, CyrusOne, Ark Data Centres - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Data Center Colocation Market - Industry Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Europe Data Center Colocation Market was valued at USD 9.45 Billion in 2024, and is projected to reach USD 35.73 Billion by 2030, rising at a CAGR of 24.82%. The Europe data center colocation market is expected to witness cumulative investments of approximately $144.03 billion, of which, the Western Europe is slated to ac...

GCC Construction Equipment Market Research Report 2025-2030 Featuring Key Vendors - Caterpillar, Komatsu, Volvo, Hitachi, SANY, XCMG, JCB, Liebherr, Kobelco, and Zoomlion - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GCC Construction Equipment Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering. The GCC Construction Equipment Market was sized at 68,499 Units in 2024, and is projected to reach 94,499 Units by 2030, rising at a CAGR of 5.51%. Governments in the UAE and Saudi Arabia continue to prioritize urban growth and diversification, with Dubai's long-term 2040 Urban Master Plan and the Saudi Vision 2030-linked mega-projects fuelling o...
Back to Newsroom